CAPPELLACCI, Loredana
 Distribuzione geografica
Continente #
NA - Nord America 21.402
EU - Europa 10.126
AS - Asia 8.283
SA - Sud America 1.039
Continente sconosciuto - Info sul continente non disponibili 825
AF - Africa 290
OC - Oceania 24
AN - Antartide 1
Totale 41.990
Nazione #
US - Stati Uniti d'America 20.628
CN - Cina 3.358
SG - Singapore 2.327
IT - Italia 2.278
RU - Federazione Russa 2.222
PL - Polonia 1.334
DE - Germania 975
BR - Brasile 856
FR - Francia 656
HK - Hong Kong 654
CA - Canada 625
VN - Vietnam 621
UA - Ucraina 611
GB - Regno Unito 576
SE - Svezia 557
FI - Finlandia 369
TR - Turchia 262
KR - Corea 254
IN - India 203
IE - Irlanda 151
ZA - Sudafrica 140
JP - Giappone 92
MX - Messico 86
BD - Bangladesh 84
CZ - Repubblica Ceca 72
ID - Indonesia 63
IR - Iran 57
ES - Italia 56
EU - Europa 52
NL - Olanda 52
IQ - Iraq 49
AR - Argentina 48
BE - Belgio 41
CO - Colombia 34
NG - Nigeria 34
EC - Ecuador 33
PK - Pakistan 33
PH - Filippine 27
AT - Austria 26
VE - Venezuela 26
MY - Malesia 25
AE - Emirati Arabi Uniti 23
MA - Marocco 19
CI - Costa d'Avorio 18
RO - Romania 18
CL - Cile 17
GR - Grecia 17
NP - Nepal 16
RS - Serbia 16
TW - Taiwan 16
AU - Australia 15
DZ - Algeria 15
UZ - Uzbekistan 15
SA - Arabia Saudita 14
TH - Thailandia 14
CM - Camerun 13
JO - Giordania 13
KE - Kenya 13
LT - Lituania 13
AL - Albania 12
IL - Israele 12
EG - Egitto 10
BG - Bulgaria 9
CH - Svizzera 9
CR - Costa Rica 9
DK - Danimarca 9
PT - Portogallo 9
DO - Repubblica Dominicana 8
HN - Honduras 8
JM - Giamaica 8
TN - Tunisia 8
PE - Perù 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
BO - Bolivia 5
EE - Estonia 5
ET - Etiopia 5
HU - Ungheria 5
KG - Kirghizistan 5
KH - Cambogia 5
BA - Bosnia-Erzegovina 4
HR - Croazia 4
LB - Libano 4
MW - Malawi 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
YE - Yemen 4
AM - Armenia 3
GP - Guadalupe 3
GT - Guatemala 3
LV - Lettonia 3
MD - Moldavia 3
PS - Palestinian Territory 3
SI - Slovenia 3
SV - El Salvador 3
BB - Barbados 2
BY - Bielorussia 2
Totale 41.168
Città #
Ashburn 1.729
Fairfield 1.548
Jacksonville 1.508
Woodbridge 1.385
Singapore 1.170
San Jose 1.149
Houston 976
Warsaw 956
Chandler 937
Council Bluffs 798
Ann Arbor 763
Dallas 718
Wilmington 704
Seattle 677
Hong Kong 627
Boardman 621
Beijing 539
Camerino 536
Cambridge 482
Nanjing 470
Toronto 395
Kraków 361
The Dalles 337
Los Angeles 329
New York 294
San Mateo 251
Seoul 223
Tongling 217
Ho Chi Minh City 208
Princeton 205
Lawrence 204
Istanbul 201
Lauterbourg 197
Helsinki 195
Columbus 192
Düsseldorf 179
Dearborn 178
Nanchang 171
Ogden 160
Hanoi 149
Dublin 144
Buffalo 130
Santa Clara 129
Chicago 122
London 119
Shanghai 118
Johannesburg 116
Moscow 116
Milan 113
Lachine 112
Tianjin 93
Shenyang 89
São Paulo 88
Orem 86
Guangzhou 84
Hebei 81
Kunming 81
Centro 77
Tokyo 74
Rome 72
San Diego 71
Jiaxing 70
Ancona 66
Washington 61
Jinan 59
Denver 57
Frankfurt am Main 57
Stockholm 56
Falls Church 55
Hangzhou 54
Bremen 52
Phoenix 52
Brooklyn 51
Changsha 49
Chennai 49
Leawood 48
Brno 46
Redwood City 44
Venezia 43
Dong Ket 42
Montreal 42
Atlanta 40
Mexico City 40
Munich 40
San Francisco 40
Trieste 40
Brussels 39
Wuhan 39
Macerata 38
Zhengzhou 38
Hefei 35
Philadelphia 34
Iesi 33
Manchester 32
Mumbai 30
Verona 30
Redondo Beach 29
Nuremberg 28
Perugia 28
Rio de Janeiro 28
Totale 26.768
Nome #
Diverse biological effects of the ajwain oil from Iranian Trachyspermum ammi 480
Trypanosoma brucei inhibition by essential oils from medicinal and aromatic plants traditionally used in Cameroon (Azadirachta indica, Aframomum melegueta, Aframomum daniellii, Clausena anisata, Dichrostachys cinerea and Echinops giganteus) 463
CHEMICAL COMPOSITION, ANTIMICROBIAL AND ANTIPROLIFERATIVE ACTIVITIES OF THE ESSENTIAL OIL FROM CAMEROONIAN ERIGERON FLORIBUNDUS 446
Biological activities of the essential oil from Erigeron floribundus 397
Mexican sunflower (Tithonia diversifolia, Asteraceae) volatile oil as a selective inhibitor of Staphylococcus aureus nicotinate mononucleotide adenylyltransferase (NadD) 385
Essential oil and furanosesquiterpenes from myrrh oleo-gum resin: a breakthrough in mosquito vector management 371
CHEMICAL COMPOSITION OF TEN ESSENTIAL OILS FROM CALOPHYLLUM INOPHYLLUM LINN AND THEIR TOXICITY AGAINST ARTEMIA SALINA 362
Efficacy of Origanum syriacum Essential Oil against the Mosquito Vector Culex quinquefasciatus and the Gastrointestinal Parasite Anisakis simplex, with Insights on Acetylcholinesterase Inhibition 360
An overlooked horticultural crop, Smyrnium olusatrum, as a potential source of compounds effective against African trypanosomiasis 335
SINTESI E VALUTAZIONE BIOLOGICA DI INIBITORI DI ENZIMI CHIAVE NEL METABOLISMO DI BIOFILM BATTERICI 332
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 321
The crop-residue of fiber hemp cv Futura 75: from a waste product to a source of botanical insecticides 311
Antitrypanosomal activity of Tithonia Diversifolia 304
4-acyl-5-pyrazolone-based hydrazones as novel anti-Trypanosoma brucei agents: structural design, synthesis and biological evaluation 297
Mosquito control with green nanopesticides: towards the One Health approach? A review of non-target effects 293
The essential oil from industrial hemp (Cannabis sativa L.) by-products as an effective tool for insect pest management in organic crops 275
8-Aza analogues of deaza purine nucleosides. Synthesis and biological evaluation of 8-aza-1-deazaadenosine and 2'-deoxy-8-aza-1-deazaadenosine 272
Identification of Onosma visianii Roots Extract and Purified Shikonin Derivatives as Potential Acaricidal Agents against Tetranychus urticae 271
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. 259
2’-C-Methyl derivatives of tecadenoson and 2-chloro-tecadenoson with increased selectivity for human A1 adenosine receptor 256
Synergized mixtures of Apiaceae essential oils and related plant-borne compounds: larvicidal effectiveness on the filariasis vector Culex quinquefasciatus Say 255
Isofuranodiene and germacrone from Smyrnium olusatrum essential oil as acaricides and oviposition inhibitors against Tetranychus urticae: impact of chemical stabilization of isofuranodiene by interaction with silver triflate 253
Oviposition inhibitory activity of the Mexican sunflower Tithonia diversifolia (Asteraceae) polar extracts against the two-spotted spider mite Tetranychus urticae (Tetranychidae) 251
Insecticidal activity of two essential oils used in perfumery (ylang ylang and frankincense). 248
Development of C-Methyl Branched Purine Ribonucleoside Analogs: Chemistry, Biological Activity and Therapeutic Potential 246
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 246
8-Azaxanthine derivatives as antagonists of adenosine receptors. 245
8-Aza-1-deaza purine nucleosides as antiviral agents. 240
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 240
ATP-mimetics derived from 2 '(3 ')-C-methyladenosine as human P2Y2 agonists 239
5’-deoxy-5’-N-pyrazolyl-N6-substituded adenosine derivates as A1 adenosine receptor agonists: synthesis and antinociception in mice 238
Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors 238
4’-TETRAZOLYL-ALKYL-N6-SUBSTITUTED ADENOSINE DERIVATIVES AS HIGHLY POTENT DUAL ACTING A1 ADENOSINE RECEPTOR AGONISTS AND A3 ADENOSINE RECEPTOR ANTAGONISTS 236
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 235
A new facile synthesis and antiviral activity of oxazofurin 234
SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF RIBOSE-MODIFIED ADENOSINE DERIVATIVES AS P1 RECEPTOR LIGANDS 233
Targeting Nucleotide Dimers Containing Antiviral Nucleosides 230
ADP- and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 receptor ligands 230
Acyclic nucleotides related to clitocine: synthesis and anti-HIV activity 229
BIOASSAY-GUIDED FRACTIONATION OF TITHONIA DIVERSIFOLIA SECONDARY METABOLITES AGAINST TRYPANOSOMA BRUCEI 229
5'-CHLORO-5'-DEOXY-N6-(±)-endo-NORBORNYLADENOSINE, A POTENT AND HIGHLY SELECTIVE HUMAN A1 ADENOSINE RECEPTOR AGONIST, PREVENTS HYPERALGESIA/ALLODYNIA AND EARLY OVER-EXPRESSION OF PRO-APOPTOTIC AND PRO-INFLAMMATORY GENES IN A MICE MODEL OF NEUROPATHIC PAIN 228
Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget-Directed Hydrazone Ruthenium(II)-Arene Complexes 228
New Half-Sandwich Ruthenium(II) Complexes bearing Hydrazone Ligands: Organometallic Chemistry and Bioactivity 226
Synthesis and antiviral activity of 8-aza analogs of chiral [2-(Phosphono-methoxy)propyl]guanines. 226
Rationale for developing novel mosquito larvicides based on isofuranodiene microemulsions 225
5’-Carbamoyl Derivatives of 2'-C-Methyl-purine Nucleosides as Selective A1 Adenosine Receptor Agonists: Affinity, Efficacy and Selectivity for A1 Receptor from Different Species. 224
5′-C-Ethyl-tetrazolyl-N6-Substituted Adenosine and 2-Chloro-adenosine Derivatives as Highly Potent Dual Acting A1 Adenosine Receptor Agonists and A3 Adenosine Receptor Antagonists 223
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir 221
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 220
Synthesis and Biological Evaluation of NAD Analogs as Human Pyridine Nucleotide Adenylyltransferase Inhibitors 219
Adenosine receptors as promising targets for the management of ocular diseases 217
Synthesis and biological activity of novel N6-substituted and 2,N6-disubstituted adenine ribo- and 3'-C-methyl-ribonucleosides as antitumor agents 216
A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex Virus 216
Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade 216
A new tiazofurin pronucleotide: synthesis and biological evaluation of CycloSaligenyl-tiazofurin monophosphate 215
Identification of highly effective antitrypanosomal compounds in essential oils from the Apiaceae family 213
Insights into the GTP‐dependent allosteric control of c‐di‐GMP hydrolysis from the crystal structure of PA0575 protein from Pseudomonas aeruginosa 213
Encapsulation of Carlina acaulis essential oil and carlina oxide to develop long‑lasting mosquito larvicides: microemulsions versus nanoemulsions 213
2'-C-Methyl analogs of selective adenosine receptors agonists: synthesis and binding studies 210
N6/5’-DISUBSTITUTED ADENOSINE AND 2-CHLORO-ADENOSINE DERIVATIVES AS POTENT AND SELECTIVE A1 ADENOSINE RECEPTOR AGONISTS: SYNTHESIS, BINDING ASSAYS AND ANTINOCICEPTIVE ACTIVITY IN MICE 210
Acute and sub-lethal toxicity of eight essential oils of commercial interest against the filariasis mosquito Culex quinquefasciatus and the housefly Musca domestica 210
Novel dual acting 5’-C-ethyl-tetrazolyl-N6-substituted adenosine derivatives: synthesis and biological evaluation 209
8-Aza derivatives of 3-deazapurine nucleosides. Synthesis and in vitro evaluation of antiviral and antitumor activity 209
Synthesis and Biological Evaluations of Novel Arene Ru(II) Complexes of 4-acyl-5-pyrazolone-based Hydrazone Ligands 208
Carlina oxide from Carlina acaulis root essential oil acts as a potent mosquito larvicide 208
Preparation of purine and 8-azapurine derivatives for treatment of acquired immune deficiency syndrome. 207
5'-Chloro-5'-deoxy-N6-(±)-endo-norbornyladenosine, a potent and highly selective human A1 adenosine receptor agonist modulates neuropathic pain in mice. 207
Purine and pyrimidine nucleoside analogs of 3'-C-methyladenosine as antitumor agents 207
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 207
8-Aza-analogues of PMEA and PMEG: synthesis and in vitro anti-HIV activity. 206
5’-CHLORO-5’-DEOXY-N6-SUBSTITUTED ADENOSINE DERIVATIVES: SYNTHESIS, ADENOSINE RECEPTOR AFFINITY AND ANTINOCICEPTIVE ACTIVITY 206
Stereoselective synthesis of nicotinamide β-riboside and nucleoside analogs 205
Pharmacokinetic and antiretroviral activity in mice of oral [P1,P2-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 205
Identification of Tagitinin C from Tithonia diversifolia as antitrypanosomal compound using bioactivity-guided fractionation 202
Synthesis and anti-HIV activity of isonucleosides and acyclic nucleotides related to clitocine 201
2'-C-Methyl-2-chloro-N6-cyclopentyladenosine, a potent and highly selective A1 adenosine receptor agonist, has antinociceptive activity and modulates RVM on-and-off cell activities 200
Synthesis, Biological Evaluation and Molecular Modeling of Ribose-modified Adenosine Analogues as Adenosine Receptor Agonists 200
Ligand Design for N,O- or N,N‐Pyrazolone-Based Hydrazones Ruthenium(II)-Arene Complexes and Investigation of Their Anticancer Activity 200
Exploring the Insecticidal Potential of Boldo (Peumus boldus) Essential Oil: Toxicity to Pests and Vectors and Non-target Impact on the Microcrustacean Daphnia magna 200
The A1 Adenosine Receptor as a New Player in Microglia Physiology 199
The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cells 199
Synthesis and evaluation of anti-HIV-1 and antitumor activity of 2',3'-didehydro-2',3'-dideoxy-3-deazaadenosine, 2',3'-dideoxy-3-deazaadenosine and some 2',3'-dideoxy-3-deazaadenosine 5'-dialkyl phosphates 198
NMN/NaMN adenylyltransferase (NMNAT) and NAD kinase (NADK) inhibitors: chemistry and potential therapeutic applications 198
Design, Synthesis, and Anticancer Activity of Novel Pyridyl and Aryl Hydrazones 198
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 197
Coordination of Hydrazone Ligands to Arene Ruthenium(II) Derivatives: Synthesis, Characterization and Bioactivity 196
Synthesis and antiviral evaluation of 1-deaza-8-aza- and 3-deaza-8-aza-purine nucleosides 196
Essential oils from Smyrnium olusatrum and their major components as potential mosquitocidal and trypanocidal agents 196
Synthesis and antitumor activity of a heterodinucleotide of BVDU and Gemcitabine 195
Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746. 194
Dinucleoside polyphosphate NAD analogs as potential NMN adenylyltransferase inhibitors. Synthesis and biological evaluation 193
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 193
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y(2) and P2Y(6) receptor agonists 193
Isosteric Analogues of Nicotinamide Adenine Dinucleotide Derived from Furanfurin, Thiophenfurin, and Selenophenfurin as Mammalian Inosine Monophosphate dehydrogenase (Type I and II) Inhibitors 193
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3’-C-methyladenosine in leukaemia cells 192
A Review of the Chemistry and Biological Activities of Acmella oleracea (“jambu”, Asteraceae), with a View to the Development of Bioinsecticides and Acaricides 191
Affinity and selectivity of tecadenoson, 2-chloro-tecadenoson and 2’-C-methyl analogues at bovine and pig A1 adenosine receptor 190
Synthesis, antitumor activity and crystallographic studies of analogues of tiazofurin 190
Developing green insecticides to manage olive fruit flies? Ingestion toxicity of four essential oils in protein baits on Bactrocera oleae 190
Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues 188
Totale 23.940
Categoria #
all - tutte 168.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.520 0 0 62 104 136 116 81 160 192 209 210 250
2022/20232.883 340 60 143 332 320 360 11 203 524 231 269 90
2023/20242.515 296 151 166 81 132 318 130 110 254 133 58 686
2024/20257.266 322 163 658 307 263 359 895 1.781 634 511 367 1.006
2025/20269.678 591 900 890 1.342 974 765 1.592 610 426 680 572 336
2026/20271.505 682 423 400 0 0 0 0 0 0 0 0 0
Totale 41.990